JENNIFER KALINOWSKI: Open Payments
NPI 1437708633 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 34 payments from 15 companies in 2025. Trend: 2023 $261 · 2024 $581 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $200 |
| Indivior Inc. | 5 | $113 |
| Dexcom, Inc. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Eisai Inc. | 1 | $33 |
| Tandem Diabetes Care, Inc. | 1 | $30 |
| PFIZER INC. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Organon LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
Products named: SUBLOCADE, VRAYLAR, Dexcom G6 Transmitter, QULIPTA, BREZTRI, Leqembi, t:slim X2 Insulin Pump with Control-IQ, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
